MONOMOLECULAR CHIMERIC T-CELL RECEPTOR FOR CARCINOEMBRYONIC ANTIGEN

摘要

The invention relates to the field of passive immunotherapy of oncological diseases, and particularly to a method of adoptive cell transfer that uses genetically-modified autologous or allogeneic cytotoxic T-lymphocytes having acquired immunogenicity against tumour cells. The invention can be used in T-cell cancer therapy.